Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB4 | P30926 | 5/20 | 0.62 |
| ▸ | CHRNA3 | P32297 | 5/20 | 0.62 |
| ▸ | CHRNA1 | P02708 | 4/20 | 0.62 |
| ▸ | CHRNB2 | P17787 | 4/20 | 0.62 |
| ▸ | CHRNA4 | P43681 | 4/20 | 0.62 |
| ▸ | CHRNA2 | Q15822 | 3/20 | 0.62 |
| ▸ | CHRNG | P07510 | 2/20 | 0.62 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.62 |
| ▸ | CHRND | Q07001 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.56 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | HTR3B | O95264 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1831991 | 1.00 | CHRNB4 (0.62) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL159159 | 0.82 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL30866535 | 0.82 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL31019621 | 0.82 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL159158 | 0.82 | CHRNB4 (0.64) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL27711151 | 0.81 | CHRNB4 (0.59) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL3452963 | 0.81 | CHRNB4 (0.62) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL1538368 | 0.81 | CHRNB4 (0.62) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL3059326 | 0.81 | CHRNB2 (0.62) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 | |
| SCHEMBL3058805 | 0.81 | CHRNB2 (0.62) | CHRNB4CHRNA3CHRNA1CHRNB2CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7452541-B2 | Hapten-carrier conjugates and uses thereof | CYTOS BIOTECHNOLOGY AG (CH) | 2008-11-18 | — | — | US | claimed |
| US-6932971-B2 | Hapten-carrier conjugates and uses thereof | CYTOS BIOTECHNOLOGY AG (CH) | 2005-08-23 | — | — | US | claimed |
| US-8232072-B2 | Smoking cessation kit and method | NABI BIOPHARMACEUTICALS (US) | 2012-07-31 | — | — | US | disclosed |
| US-20110182918-A1 | Personalized drug treatment and smoking cessation kit and method | NABI BIOPHARMACEUTICALS | 2011-07-28 | — | — | US | disclosed |
| EP-2320898-A2 | SMOKING CESSATION KIT AND METHOD | Nabi Biopharmaceuticals (US) | 2011-05-18 | — | — | EP | disclosed |
| US-20100040638-A1 | SMOKING CESSATION KIT AND METHOD | NABI BIOPHARMACEUTICALS | 2010-02-18 | — | — | US | disclosed |
| WO-2009152164-A2 | SMOKING CESSATION KIT AND METHOD | NABI BIOPHARMACEUTICALS (US) | 2009-12-17 | — | — | WO | disclosed |
| EP-0801527-B1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | TARGACEPT INC (US) | 2006-07-26 | — | — | EP | disclosed |
| EP-0873050-B1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS | TARGACEPT INC (US) | 2004-03-10 | — | — | EP | disclosed |
| US-6656469-B1 | Treatment of nicotine dependence from tobacco products | INDEPENDENT PHARMACEUTICA AB (SE) | 2003-12-02 | — | — | US | disclosed |
| EP-0801527-A4 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | REYNOLDS TOBACCO CO R (US) | 2001-09-05 | — | — | EP | disclosed |
| US-5726316-A | PYRIDINYL DERIVATIVES WITH 3-BUTENE-1-AMINE | TARGACEPT, INC. | 1998-03-10 | — | — | US | disclosed |
| EP-0801646-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1997-10-22 | — | — | EP | disclosed |
| EP-0801527-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1997-10-22 | — | — | EP | disclosed |
| US-5616707-A | N-METHYL-4-PYRIDYL-3-BUT(ENE OR YNE)-1-AMINE | TARGACEPT, INC. | 1997-04-01 | — | — | US | disclosed |
| US-5604231-A | NON-STEROIDAL ANTIINFLAMMATORY AGENTS, DOPAMINERGIC AGENTS; SIDE EFFECT REDUCTION | TARGACEPT, INC. | 1997-02-18 | — | — | US | disclosed |
| US-5597919-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS RESULTING FROM NEUROTRANSMITTER DYSFUNCTION | TARGACEPT, INC., A CORPORATION OF DELAWARE | 1997-01-28 | — | — | US | disclosed |
| WO-1996020929-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1996-07-11 | — | — | WO | disclosed |
| WO-1996020599-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF ULCERATIVE COLITIS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1996-07-11 | — | — | WO | disclosed |
| WO-1996020600-A1 | PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | R.J. REYNOLDS TOBACCO COMPANY (US) | 1996-07-11 | — | — | WO | disclosed |